The risk factors of mild decline in estimated glomerular filtration rate in a community-based population

Clinical Biochemistry

Volumn 46, Issue 9, 2013, Pages 750-754

  Ji, Baolan ^a   Zhang, Suhua ^a   Gong, Lilin ^a   Wang, Zhihong ^a   Ren, Wei ^a   Li, Qifu ^a   Li, Rong ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

Chronic kidney disease; Estimated glomerular filtration rate; Fasting plasma glucose; Systolic blood pressure; Uric acid; Waist circumference

Indexed keywords

CREATININE; LIPID; URIC ACID;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD PRESSURE; CHRONIC KIDNEY DISEASE; COMMUNITY; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; URIC ACID BLOOD LEVEL;

ADULT; AGED; BLOOD GLUCOSE; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; MALE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URIC ACID; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84877826799     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.01.011     Document Type: Article

References (33)

1. Couser W.G., Remuzzi G., Mendis S., Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011, 80:1258-1270.
2. Fox C.S., Larson M.G., Leip E.P., Culleton B., Wilson P.W., Levy D. Predictors of new-onset kidney disease in a community-based population. JAMA 2004, 291:844-850.
3. Hermans M.M., Henry R., Dekker J.M., Kooman J.P., Kostense P.J., Nijpels G., et al. Estimated glomerular filtration rate and urinary albumin excretion are independently associated with greater arterial stiffness: the Hoorn Study. J Am Soc Nephrol 2007, 18:1942-1952.
4. Henry R.M., Kostense P.J., Bos G., Dekker J.M., Nijpels G., Heine R.J., et al. Mild renal insufficiency is associated with increased cardiovascular mortality: the Hoorn Study. Kidney Int 2002, 62:1402-1407.
5. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999, 130:461-470.
6. Stevens L.A., Coresh J., Feldman H.I., Greene T., Lash J.P., Nelson R.G., et al. Evaluation of the modification of diet in renal disease study equation in a large diverse population. J Am Soc Nephrol 2007, 18:2749-2757.
7. Levey A.S., Stevens L.A., Schmid C.H., Zhang Y.L., Castro A.F., Feldman H.I., et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009, 150:604-612.
8. 2. Am J Kidney Dis 2010, 56:486-495.
9. Thomas G., Sehgal A.R., Kashyap S.R., Srinivas T.R., Kirwan J.P., Navaneethan S.D. Metabolic syndrome and kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 2011, 6:2364-2373.
10. Pinto-Sietsma S.J., Navis G., Janssen W.M., de Zeeuw D., Gans R.O., de Jong P.E., et al. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003, 41:733-741.
11. Samuelsson O., Aurell M., Knight-Gibson C., Alaupovic P., Attman P.O. Apolipoprotein-B-containing lipoproteins and the progression of renal insufficiency. Nephron 1993, 63:279-285.
12. He S., Chen X.P., Jiang L.Y., Peng Y., Gong L., Chen X.N., et al. Association between serum uric acid and early kidney damage in middle-aged and elderly. Zhonghua Yi Xue Za Zhi 2010, 90:658-661. [Article in Chinese].
13. Wang F., Ye P., Luo L., Xiao W., Wu H. Association of risk factors for cardiovascular disease and glomerular filtration rate: a community-based study of 4,925 adults in Beijing. Nephrol Dial Transplant 2010, 25:3924-3931.
14. Alberti K.G., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
15. Altunkan S., Genç Y., Altunkan E. A comparative study of an ambulatory blood pressure measuring device and a wrist blood pressure monitor with a position sensor versus a mercury sphygmomanometer. Eur J Intern Med 2007, 18:118-123.
16. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28:412-419.
17. Joint committee for developing Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chinese guidelines on prevention and treatment of dyslipidemia in adults. Chin J Cardiol 2007, 35:390-419. [in Chinese].
18. Evans P.D., McIntyre N.J., Fluck R.J., McIntyre C.W., Taal M.W. Anthropomorphic measurements that include central fat distribution are more closely related with key risk factors than BMI in CKD stage 3. PLoS One 2012, 7:e34699.
19. Després J.P., Lemieux I., Bergeron J., Pibarot P., Mathieu P., Larose E., et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008, 28:1039-1049.
20. Sarafidis P.A., Ruilope L.M. Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications. Am J Nephrol 2006, 26:232-244.
21. Wolf G., Chen S., Han D.C., Ziyadeh F.N. Leptin and renal disease. Am J Kidney Dis 2002, 39:1-11.
22. Cheng L.T., Gao Y.L., Gu Y., Zhang L., Bi S.H., Tang W., et al. Stepwise increase in the prevalence of isolated systolic hypertension with the stages of chronic kidney disease. Nephrol Dial Transplant 2008, 23:3895-3900.
23. Strandberg T.E., Salomaa V.V., Vanhanen H.T., Pitkälä K., Miettinen T.A. Isolated diastolic hypertension, pulse pressure, and mean arterial pressure as predictors of mortality during a follow-up of up to 32years. J Hypertens 2002, 20:399-404.
24. Lackland D.T., Egan B.M. The dominant role of systolic hypertension as a vascular risk factor: evidence from the southeastern United States. Am J Med Sci 1999, 318:365-368.
25. Wang M.C., Tsai W.C., Chen J.Y., Huang J.J. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005, 45:494-501.
26. Lucove J., Vupputuri S., Heiss G., North K., Russell M. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study. Am J Kidney Dis 2008, 51:21-28.
27. Kitiyakara C., Yamwong S., Cheepudomwit S., Domrongkitchaiporn S., Unkurapinun N., Pakpeankitvatana V., et al. The metabolic syndrome and chronic kidney disease in a Southeast Asian cohort. Kidney Int 2007, 71:693-700.
28. Tabák A.G., Jokela M., Akbaraly T.N., Brunner E.J., Kivimäki M., Witte D.R. Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 2009, 373:2215-2221.
29. Attman P.O., Samuebsson O., Alaupovie P. Lipid metabolism and renal failure. Am J Kidney Dis 1993, 21:573-592.
30. Onat A., Hergenç G., Uyarel H., Ozhan H., Esen A.M., Karabulut A., et al. Association between mild renal dysfunction and insulin resistance or metabolic syndrome in a random nondiabetic population sample. Kidney Blood Press Res 2007, 30:88-96.
31. Sonoda H., Takase H., Dohi Y., Kimura G. Uric acid levels predict future development of chronic kidney disease. Am J Nephrol 2011, 33:352-357.
32. Kanbay M., Huddam B., Azak A., Solak Y., Kadioglu G.K., Kirbas I., et al. A randomized study of allopurinol on endothelial function and estimated glomular filtration rate in asymptomatic hyperuricemic subjects with normal renal function. Clin J Am Soc Nephrol 2011, 6:1887-1894.
33. Nakagawa T., Mazzali M., Kang D.H., Kanellis J., Watanabe S., Sanchez-Lozada L.G., et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 2003, 23:2-7.